Stem cell shot for knee pain shows promise in early trial
NCT ID NCT06084988
First seen May 07, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This early-stage study tested a single injection of StromaForte, a stem cell product, in 12 people with mild-to-moderate knee osteoarthritis. The main goal was to check safety and tolerability over 24 weeks. Researchers also looked at whether the treatment reduced knee pain. The study is complete, but results are not yet reported.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEO ARTHRITIS KNEE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Burjeel Medical City
Abu Dhabi, United Arab Emirates
Conditions
Explore the condition pages connected to this study.